Volitionrx earnings were -$26.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest VNRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$7.8M, up 16.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VNRX reported annual earnings of -$23.4M, with -13.4% growth. The next VNRX earnings date is Nov 12, 2026.
On VNRX's earnings call on Aug 13, 2026, Volitionrx (NYSEMKT: VNRX) reported Q2 2026 earnings per share (EPS) of -$0.85, up 30.33% year over year. Total VNRX earnings for the quarter were -$7.79 million. In the same quarter last year, Volitionrx's earnings per share (EPS) was -$1.22.
The next VNRX earnings call is Nov 12, 2026. Add VNRX to your watchlist to be reminded of Volitionrx's next earnings date.
Is Volitionrx profitable or losing money?
As of the last Volitionrx earnings report, Volitionrx is currently losing money. Volitionrx's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$25.64 million, a 9.94% increase year over year.
What was VNRX's earnings growth in the past year?
As of Volitionrx's earnings date in Aug 13, 2026, Volitionrx's earnings has grown year over year. VNRX earnings in the past year totalled -$26.10 million.
What are Volitionrx's earnings expectations?
The current EPS estimate for Volitionrx's earnings report in Nov 12, 2026 is -$0.48.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.